CNP
50
-2
MA
67
-5
INTC
49
16
LB
63
-4
MAT
38
-3
HPE
70
2
JCI
61
-2
XEL
65
-2
XRX
34
-3
URBN
66
2
IVZ
49
-3
KLAC
45
-4
NI
73
3
CSX
68
3
TEL
74
3
LEN
52
2
LNC
45
-4
MLM
57
-3
PNR
74
5
PX
73
-6
CNP
50
-2
MA
67
-5
INTC
49
16
LB
63
-4
MAT
38
-3
HPE
70
2
JCI
61
-2
XEL
65
-2
XRX
34
-3
URBN
66
2
IVZ
49
-3
KLAC
45
-4
NI
73
3
CSX
68
3
TEL
74
3
LEN
52
2
LNC
45
-4
MLM
57
-3
PNR
74
5
PX
73
-6
Financhill
Back

Mesoblast Quote, Financials, Valuation and Earnings

Trump's IRS Hands Massive 'Victory Gift' To 401K Owners

Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Buy
59

MESO
Mesoblast

Last Price:
11.47
Seasonality Move:
5.45%

7 Day Trial

ALL ACCESS PASS

$ 7

America's enemies are regrouping & it may sucker punch your savings

Click here to learn more.

Mesoblast Price Quote

$11.47
-0.23 (-1.97%)
(Updated: November 14, 2024 at 12:10 PM ET)

Mesoblast Key Stats

Buy
59
Mesoblast (MESO) is a Buy
Day range:
$10.50 - $12.18
52-week range:
$1.61 - $11.05
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
793.4K
Avg. volume:
202.6K
1-year change:
357.03%
Market cap:
$1.1B
Revenue:
$5.9M
EPS:
$53.02

How Much Does Mesoblast Make?

  • How Much Are Mesoblast's Sales Annually?
    MESO Revenues are $5.9M
  • How Much Profit Does Mesoblast's Make A Year?
    MESO net income is -$88M

Is Mesoblast Growing As A Company?

  • What Is Mesoblast's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.04%
  • What Is Mesoblast's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.23%

Mesoblast Stock Price Performance

  • Did Mesoblast Stock Go Up Last Month?
    Mesoblast share price went up by 16.07% last month
  • Did MESO's Share Price Rise Over The Last Year?
    MESO share price rose by 357.03% over the past 1 year

What Is Mesoblast 52-Week High & Low?

  • What Is Mesoblast’s 52-Week High Share Price?
    Mesoblast has traded as high as $11.05 over the past 52 weeks
  • What Is Mesoblast’s 52-Week Low Share Price?
    Mesoblast has traded as low as $1.61 over the past 52 weeks

Mesoblast Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Mesoblast?

  • How Much Debt Does Mesoblast Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Mesoblast Have?
    Cash and short term investments quarterly total is $70.9M
  • What Is Mesoblast’s Book Value Per Share?
    Book value per share is 5.85

Is Mesoblast Cash Flow Positive?

  • What Is MESO Cash Flow From Operations?
    Cash flow from operations (TTM) is -$63.3M
  • What Is Mesoblast’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $74.5M
  • What Is Mesoblast’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$194K

Mesoblast Return On Invested Capital

Data Unavailable

Mesoblast Earnings Date & Stock Price

  • What Is Mesoblast's Stock Price Today?
    A single share of MESO can be purchased today for 11.70
  • What Is Mesoblast’s Stock Symbol?
    Mesoblast trades on the nasdaq under the ticker symbol: MESO
  • When Is Mesoblast’s Next Earnings Date?
    The next quarterly earnings date for Mesoblast is scheduled on January 31, 2025
  • When Is MESO's next ex-dividend date?
    Mesoblast's next ex-dividend date is November 14, 2024
  • How To Buy Mesoblast Stock?
    You can buy Mesoblast shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Mesoblast Competitors

  • Who Are Mesoblast's Competitors?
    Below is a list of companies who compete with Mesoblast or are related in some way:
    • Alterity Therapeutics Ltd (ATHE)
    • Immutep Ltd (IMMP)
    • Immuron Ltd (IMRN)
    • Kazia Therapeutics Ltd (KZIA)
    • Opthea Ltd (OPT)

Mesoblast Dividend Yield

  • What Is MESO Dividend Yield?
    Mesoblast’s dividend yield currently is 0%
  • What Is Mesoblast’s Payout Ratio?
    Mesoblast’s payout ratio is 0%
  • When Did Mesoblast Last Pay A Dividend?
    The latest dividend pay date is November 14, 2024
  • What Is Mesoblast’s Dividend Per Share?
    Mesoblast pays a dividend of $0.00 per share

Mesoblast Analyst Estimates

YoY Growth Past Surprise
EPS: -23.12% 4.93%
Revenue: -3.82% -10.12%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 14.50
Upside from Last Price: 23.93%

Major Shareholders

  • How many MESO shares are owned by institutional investors?
    1.4M MESO shares are owned by institutional investors
  • How many MESO shares are owned by insiders?
    0 MESO shares are owned by insiders